Abstract
Objective
To determine how well patients could correctly recognize and comprehend the various information items on patient information leaflets, and to explore the reasons underlying poor comprehensibility.
Methods
Leaflets from 30 randomly selected, commonly prescribed medicines were examined by experts using protocols to evaluate leaflet layout, language and content. The same leaflets were also evaluated by patients who had their medicines dispensed at 24 randomly selected Swedish pharmacies. A questionnaire was used for the patients’ examination.
Results
The results showed that most information on the leaflets is sound and is well comprehended by the patients. For two information items regarding ’risks of interactions’ and ’contraindications’ the patient scores were low, indicating poor comprehensibility.
Conclusion
Leaflets with low scores on warnings of interactions and contraindications were found to deliver more complex messages to older patients as compared to leaflets with high scores for these items.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Reference
P Meredith M Emberton C. Wood (1995) ArticleTitleNew directions in information for patients. More attention should be given to finding out what works BMJ 311 4–5 Occurrence Handle1:STN:280:ByqA3sjps10%3D Occurrence Handle7613327
DK. Raynor (1992) ArticleTitlePatient compliance – the pharmacist’s role Int J Pharm Prac 1 126–35
LA Morris KJ. Aikin (2001) ArticleTitleThe ’pharmacokinetics’ of patient communications Drug Inform J 35 509–27
DK Raynor P. Knapp (2000) ArticleTitleDo patients see, read and retain the new mandatory medicines information leaflets? Pharm J 264 260–70
European Union Directive 92/27 EEC. www.europa.eu.int (April 14, 2004).
A. Coulter (1998) ArticleTitleEvidence based patient information BMJ 317 225–6 Occurrence Handle1:STN:280:DyaK1czkt1akuw%3D%3D Occurrence Handle9677206
D Dickinson DK Raynor M. Duman (2001) ArticleTitlePatient information leaflets for medicines: using consumer testing to determine the most effective design Patient Educ Couns 43 147–59 Occurrence Handle10.1016/S0738-3991(00)00156-7 Occurrence Handle1:STN:280:DC%2BD38%2FhtFSltw%3D%3D Occurrence Handle11369148
European Union Guideline on the packing information of medical products for human use authorized by the Community. www.emea.eu.int (April 14, 2004).
European Union Guideline on the readability of the label and package leaflet of medical products for human use. www.emea.eu.int (April 14, 2004).
R Brockmeyer L Steindl I Behrens S Gnekow F Verheyen M. Schulz (2001) ArticleTitleTesting of the readability of package inserts at a community pharmacy Pharm Ind 63 114–119
K Azodi S Himstedt A Hinrichs M Krüger S Schrader M. Schulz (2002) ArticleTitleTesting of the readability of package leaflets as an initial step under the pharmaceutical care initiative towards increasing the safety of medicinal products Pharm Ind 64 1119–25
J Gustafsson S Kälvemark G Nilsson JLG. Nilsson (2003) ArticleTitleA method to evaluate patient information leaflets Drug Inform J 37 115–125
InstitutionalAuthorNameFASS (1999) Läkemedel i Sverige [Specifications of drugs approved in Sweden] LIF Stockholm, Sweden
D Isacson K. Bingefors (2002) ArticleTitleAttitudes towards drugs – a survey in the general population Pharm World Sci 24 104–110 Occurrence Handle10.1023/A:1016127320051 Occurrence Handle1:STN:280:DC%2BD38zovVGjsQ%3D%3D Occurrence Handle12136742
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gustafsson, J., Kälvemark, S., Nilsson, G. et al. Patient information leaflets — patients’ comprehension of information about interactions and contraindications. Pharm World Sci 27, 35–40 (2005). https://doi.org/10.1007/s11096-005-1413-x
Issue Date:
DOI: https://doi.org/10.1007/s11096-005-1413-x